This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for lutonix dcb is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo, restenotic, or in-stent restenotic lesions up to 300 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-7 mm.
Device | LUTONIX 035 DRUG COATED BALLOON PTA CATHETER |
Classification Name | Drug-eluting Peripheral Transluminal Angioplasty Catheter |
Generic Name | Drug-eluting Peripheral Transluminal Angioplasty Catheter |
Applicant | LUTONIX |
Date Received | 2016-01-04 |
Decision Date | 2017-02-07 |
Notice Date | 2017-02-15 |
PMA | P130024 |
Supplement | S009 |
Product Code | ONU |
Docket Number | 17M-0831 |
Advisory Committee | Cardiovascular |
Supplement Type | Panel Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | Yes |
Applicant Address | LUTONIX 9409 Science Center Dr new Hope, MN 55428 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling Labeling Part 2 |
Post-Approval Study: | Show Report Schedule and Study Progress |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P130024 | Original Filing | |
S042 | 2021-11-18 | 30-day Notice |
S041 | 2021-07-06 | 30-day Notice |
S040 | 2021-03-08 | Real-time Process |
S039 | ||
S038 | ||
S037 | 2020-09-30 | Real-time Process |
S036 | 2020-04-13 | 30-day Notice |
S035 | ||
S034 | ||
S033 | 2019-11-29 | Real-time Process |
S032 | 2019-11-25 | 30-day Notice |
S031 | ||
S030 | 2019-09-20 | Normal 180 Day Track |
S029 | 2019-09-03 | Special (immediate Track) |
S028 | ||
S027 | 2019-02-26 | Real-time Process |
S026 | 2018-11-16 | Real-time Process |
S025 | 2018-10-04 | Real-time Process |
S024 | 2018-06-25 | Real-time Process |
S023 | 2018-06-20 | 30-day Notice |
S022 | 2018-01-25 | Normal 180 Day Track |
S021 | 2017-12-08 | Normal 180 Day Track No User Fee |
S020 | 2017-09-25 | Normal 180 Day Track No User Fee |
S019 | ||
S018 | 2017-02-06 | 30-day Notice |
S017 | 2016-11-28 | 30-day Notice |
S016 | ||
S015 | 2016-08-15 | Normal 180 Day Track No User Fee |
S014 | 2016-07-05 | Normal 180 Day Track |
S013 | 2016-06-15 | Normal 180 Day Track No User Fee |
S012 | 2016-04-29 | Special (immediate Track) |
S011 | 2016-03-25 | Normal 180 Day Track No User Fee |
S010 | 2016-01-27 | Real-time Process |
S009 | 2016-01-04 | Panel Track |
S008 | 2015-11-09 | Special (immediate Track) |
S007 | 2015-08-07 | Special (immediate Track) |
S006 | 2015-07-13 | Normal 180 Day Track No User Fee |
S005 | 2015-06-02 | Normal 180 Day Track |
S004 | 2015-03-02 | Real-time Process |
S003 | 2015-02-25 | 135 Review Track For 30-day Notice |
S002 | 2015-01-12 | Normal 180 Day Track |
S001 | 2014-11-24 | Real-time Process |